Propanc Biopharma, Inc.(PPCB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PPCB Propanc Biopharma, Inc.

已收盘 02-26 16:00:00 EST

0.1952

-0.0063

-3.13%

盘后0.1959

+0.0007+0.36%

19:52 EST

最高0.2199	最低0.1950	成交量26.08万
今开0.2081	昨收0.2015	日振幅12.36%
总市值309.57万	流通市值131.45万	总股本1,586万
成交额5.33万	换手率3.87%	流通股本673.39万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"PPCB","market":"US","secType":"STK","nameCN":"Propanc Biopharma, Inc.","latestPrice":0.1952,"timestamp":1772139600000,"preClose":0.2015,"halted":0,"volume":260801,"hourTrading":{"tag":"盘后","latestPrice":0.1959,"preClose":0.1952,"latestTime":"19:52 EST","volume":8105,"amount":1595.0738,"timestamp":1772153570504,"change":0.0007,"changeRate":0.003586,"amplitude":0.024078},"delay":0,"changeRate":-0.031265508684863524,"floatShares":6733900,"shares":15859300,"eps":-13.5424,"marketStatus":"已收盘","change":-0.0063,"latestTime":"02-26 16:00:00 EST","open":0.208074,"high":0.2199,"low":0.195,"amount":53298.71633346,"amplitude":0.123573,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-13.5424,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1772182800000},"marketStatusCode":5,"adr":0,"listingDate":1743998400000,"exchange":"NASDAQ","adjPreClose":0.2015,"preHourTrading":{"tag":"盘前","latestPrice":0.2069,"preClose":0.2015,"latestTime":"09:02 EST","volume":7598,"amount":1531.58189404,"timestamp":1772114527568,"change":0.0054,"changeRate":0.026799,"amplitude":0.026799},"postHourTrading":{"tag":"盘后","latestPrice":0.1959,"preClose":0.1952,"latestTime":"19:52 EST","volume":8105,"amount":1595.0738,"timestamp":1772153570504,"change":0.0007,"changeRate":0.003586,"amplitude":0.024078},"volumeRatio":0.588425},"requestUrl":"/m/hq/s/PPCB","defaultTab":"news","newsList":[{"id":"1195378168","title":"Propanc Biopharma提交招股说明书 持股股东拟转售200万股","url":"https://stock-news.laohu8.com/highlight/detail?id=1195378168","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195378168?lang=zh_cn&edition=full","pubTime":"2025-12-30 19:08","pubTimestamp":1767092892,"startTime":"0","endTime":"0","summary":"Propanc Biopharma, Inc. 已向美国证券交易委员会（SEC）提交招股说明书，文件显示公司一名持股股东计划公开转售所持有的200万股普通股。此次股份转售属于股东个人行为，公司本身不会从此次交易中获得任何资金。该招股说明书为二级市场流通提供了必要法律依据，意味着现有股东可能通过公开市场减持其投资头寸。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PPCB","BK4139"],"gpt_icon":0},{"id":"2593429246","title":"Propanc Biopharma, Inc.盘中异动 急速上涨6.48%报0.693美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593429246","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593429246?lang=zh_cn&edition=full","pubTime":"2025-12-23 22:39","pubTimestamp":1766500770,"startTime":"0","endTime":"0","summary":"北京时间2025年12月23日22时39分，Propanc Biopharma, Inc.股票出现波动，股价大幅拉升6.48%。Propanc Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Liminatus Pharma Inc C/Wts 30/04/2030 、Celularity Inc C/Wts 16/07/2026 涨幅较大，Lexaria Bioscience Corp.、Pmgc Holdings Inc.、Reviva Pharmaceuticals Holdings, Inc.较为活跃，换手率分别为62.32%、19.47%、17.58%，振幅较大的相关个股有健永生技、Chemomab Therapeutics Ltd、Moolec Science Sa，振幅分别为22.93%、20.10%、14.61%。Propanc Biopharma, Inc.公司简介：Propanc Biopharma Inc是一家处于发展阶段的医疗保健公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223223930953b9123&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223223930953b9123&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PPCBD","PPCB","BK4139"],"gpt_icon":0},{"id":"2587998737","title":"Propanc Biopharma, Inc.盘中异动 早盘股价大涨5.23%报0.847美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2587998737","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2587998737?lang=zh_cn&edition=full","pubTime":"2025-11-28 23:38","pubTimestamp":1764344314,"startTime":"0","endTime":"0","summary":"北京时间2025年11月28日23时38分，Propanc Biopharma, Inc.股票出现波动，股价急速拉升5.23%。Propanc Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Pasithea Therapeutics Corp.、Liminatus Pharma Inc C/Wts 30/04/2030 涨幅较大，Aditxt, Inc.、Pasithea Therapeutics Corp.、Cdt Equity Inc.较为活跃，换手率分别为3825.43%、1505.30%、241.69%，振幅较大的相关个股有Pasithea Therapeutics Corp C/Wts 12/08/2026 、Pasithea Therapeutics Corp.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为111.14%、67.92%、35.60%。Propanc Biopharma, Inc.公司简介：Propanc Biopharma Inc是一家处于发展阶段的医疗保健公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128233835a717e595&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128233835a717e595&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PPCBD","BK4139","PPCB"],"gpt_icon":0},{"id":"2583579368","title":"Propanc Biopharma, Inc.盘中异动 早盘股价大跌5.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583579368","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583579368?lang=zh_cn&edition=full","pubTime":"2025-11-14 00:09","pubTimestamp":1763050183,"startTime":"0","endTime":"0","summary":"北京时间2025年11月14日00时09分，Propanc Biopharma, Inc.股票出现波动，股价大幅下跌5.64%。Propanc Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.56%。其相关个股中，Mersana Therapeutics, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 、Outlook Therapeutics, Inc.涨幅较大，Clearmind Medicine Inc.、Salarius Pharmaceuticals, Inc.、Outlook Therapeutics, Inc.较为活跃，换手率分别为4887.22%、407.27%、67.00%，振幅较大的相关个股有Clearmind Medicine Inc.、Outlook Therapeutics, Inc.、Osr Holdings Inc C/Wts 09/02/2028 ，振幅分别为107.67%、30.47%、29.51%。Propanc Biopharma, Inc.公司简介：Propanc Biopharma Inc是一家处于发展阶段的医疗保健公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114000944950293d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114000944950293d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PPCB","BK4139","PPCBD"],"gpt_icon":0},{"id":"2582165663","title":"Propanc Biopharma, Inc.盘中异动 大幅跳水5.65%报0.851美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582165663","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582165663?lang=zh_cn&edition=full","pubTime":"2025-11-11 23:41","pubTimestamp":1762875678,"startTime":"0","endTime":"0","summary":"北京时间2025年11月11日23时41分，Propanc Biopharma, Inc.股票出现波动，股价大幅下挫5.65%。Propanc Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。其相关个股中，Engene Holdings Inc C/Wts 31/10/2028  Cl A、Engene Holdings Inc.、Quoin Pharmaceuticals Ltd涨幅较大，Quoin Pharmaceuticals Ltd、Aspire Biopharma Holdings, Inc.、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为2627.31%、345.35%、282.14%，振幅较大的相关个股有Engene Holdings Inc C/Wts 31/10/2028  Cl A、Quoin Pharmaceuticals Ltd、Engene Holdings Inc.，振幅分别为72.31%、58.48%、54.91%。Propanc Biopharma, Inc.公司简介：Propanc Biopharma Inc是一家处于发展阶段的医疗保健公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511112341189762cb1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511112341189762cb1d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PPCBD","PPCB"],"gpt_icon":0},{"id":"1130774186","title":"Propanc Biopharma, Inc. 进行战略收购计划，瞄准市值低于净资产价值的数字资产财政公司","url":"https://stock-news.laohu8.com/highlight/detail?id=1130774186","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130774186?lang=zh_cn&edition=full","pubTime":"2025-11-04 20:01","pubTimestamp":1762257670,"startTime":"0","endTime":"0","summary":"Propanc Biopharma, Inc. 进行战略收购计划，瞄准市值低于净资产价值的数字资产财政公司。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PPCB","BK4139"],"gpt_icon":0},{"id":"1139253764","title":"Propanc Biopharma与Hexstone Capital达成高达1亿美元的战略融资协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1139253764","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139253764?lang=zh_cn&edition=full","pubTime":"2025-10-15 20:45","pubTimestamp":1760532334,"startTime":"0","endTime":"0","summary":"Propanc Biopharma与Hexstone Capital达成高达1亿美元的战略融资协议","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PPCB"],"gpt_icon":0},{"id":"1187004928","title":"美国监管、财库模式强劲、财报给力，降息后首日，币圈“币股齐升”","url":"https://stock-news.laohu8.com/highlight/detail?id=1187004928","media":"华尔街见闻","labels":["economic"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187004928?lang=zh_cn&edition=full","pubTime":"2025-09-19 16:44","pubTimestamp":1758271470,"startTime":"0","endTime":"0","summary":"美联储降息首日，加密货币市场全面上涨，比特币突破11.7万美元，数字资产交易所股价大涨。监管转向、资金涌入与亮眼财报形成共振效应：一是SEC新规将数字资产ETF审批时间从240天缩短至75天，为更多加密货币ETF铺路；二是财库模式获追捧，木头姐联手阿联酋3亿美元押注Solana财库公司；三是Bullish交易所扭亏为盈并获得纽约监管牌照。","market":"us","thumbnail":"https://static.tigerbbs.com/6f743d717b6a2f2140fa7df544d4c12c","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6f743d717b6a2f2140fa7df544d4c12c"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"be98285368f3586ab1487190e5f718fe","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLSK","SOS","09618","BTC.USD.CC","BITB","BTCO","02888","02598","AAVE.USD.CC","LTC.USD.CC","ETH","ETH.USD.CC","HODL","BTBT","ICG","OP.USD.HKCC","CETH","RIOT","COMP.USD.CC","06060","FBTC","IBIT","EBON","PPCB","09923","COSM","MATIC.USD.CC","MKR.USD.CC","QETH","BTCT","SBET","AVAX.USD.CC","USDT.USD.CC","ETHE","UNI.USD.CC","LINK.USD.CC","BTCW","COIN","NCTY","LDO.USD.HKCC","DEFI","FETH","ARKB","BTM","GBTC","BITO","00165","EZBC","BRRR","ATOM.USD.HKCC","DOT.USD.CC","MSTR","01328","BTCS","CAN","BTCM","ETHA","MARA","RNDR.USD.HKCC","DYDX.USD.HKCC","ETHV","EZET","ETHW","09959","BMNR","SNX.USD.CC","00863"],"gpt_icon":1},{"id":"1197229382","title":"特朗普儿子：加密货币将“拯救美元”","url":"https://stock-news.laohu8.com/highlight/detail?id=1197229382","media":"华尔街见闻","labels":["economic"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197229382?lang=zh_cn&edition=full","pubTime":"2025-09-19 08:44","pubTimestamp":1758242675,"startTime":"0","endTime":"0","summary":"据报道，Eric Trump称，通过吸引全球资本流入美国数字资产市场，可以为美元提供新的支撑。他的核心逻辑是，一个对数字资产友好的美国将成为全球资本的避风港。当投资者寻求将资金从“不稳定的货币”中转移出来时，美国的加密市场将提供一个有吸引力的选择，从而间接支撑对美元计价资产的需求。\n","market":"us","thumbnail":"https://community-static.tradeup.com/news/2dab22c0fef63e984abe5f41f3c51132","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/2dab22c0fef63e984abe5f41f3c51132"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2c96d496c4829a01b5c378e5f9b4cc21","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SOS","BTM","CLSK","BRRR","DOT.USD.CC","QETH","09618","ETHA","09923","BITO","01328","DEFI","LTC.USD.CC","HODL","00165","SBET","COMP.USD.CC","COIN","BTCT","EZET","RNDR.USD.HKCC","EBON","ATOM.USD.HKCC","ETH","BMNR","PPCB","BTCW","02888","SNX.USD.CC","LDO.USD.HKCC","UNI.USD.CC","RIOT","BTCO","FBTC","ETH.USD.CC","NCTY","ICG","BTCM","FETH","IBIT","EZBC","00863","CETH","GBTC","LINK.USD.CC","09959","ETHE","ETHV","BITB","MKR.USD.CC","CAN","ETHW","MATIC.USD.CC","06060","MARA","USDT.USD.CC","AAVE.USD.CC","BTBT","DYDX.USD.HKCC","MSTR","OP.USD.HKCC","BTC.USD.CC","COSM","BTCS","02598","AVAX.USD.CC","ARKB"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.propanc.com","stockEarnings":[{"period":"1week","weight":-0.0405},{"period":"1month","weight":-0.2778},{"period":"3month","weight":-0.7498},{"period":"6month","weight":-0.9333},{"period":"1year","weight":1006.5},{"period":"ytd","weight":-0.6245}],"compareEarnings":[{"period":"1week","weight":0.01},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0198},{"period":"6month","weight":0.0746},{"period":"1year","weight":0.1664},{"period":"ytd","weight":0.0165}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Propanc Biopharma, Inc.最初于2007年10月15日在澳大利亚维多利亚州墨尔本成立。2010年11月23日，该公司在特拉华州重新注册并重新注册。他们是一家发展阶段的医疗保健公司，目前专注于为患有胰腺癌、卵巢癌和癌症的患者开发新的癌症治疗方法。利用他们的科学和肿瘤学顾问，他们开发了一种合理的抗癌化合物复合配方，这些化合物共同发挥多种作用，旨在控制或防止肿瘤在体内复发和扩散。他们的主要候选产品PRP是他们新配方的变体，涉及酶原，即酶的无活性前体。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.358631},{"month":2,"riseRate":0,"avgChangeRate":-0.328762},{"month":3,"riseRate":0,"avgChangeRate":-0.122004},{"month":4,"riseRate":0,"avgChangeRate":-0.570113},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.073453},{"month":6,"riseRate":0.666667,"avgChangeRate":0.742287},{"month":7,"riseRate":0.25,"avgChangeRate":-0.019906},{"month":8,"riseRate":0,"avgChangeRate":-0.482224},{"month":9,"riseRate":0,"avgChangeRate":-0.414214},{"month":10,"riseRate":0,"avgChangeRate":-0.267792},{"month":11,"riseRate":0,"avgChangeRate":-0.325477},{"month":12,"riseRate":0.25,"avgChangeRate":-0.177783}],"exchange":"NASDAQ","name":"Propanc Biopharma, Inc.","nameEN":"Propanc Biopharma, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Propanc Biopharma, Inc.(PPCB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Propanc Biopharma, Inc.(PPCB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Propanc Biopharma, Inc.,PPCB,Propanc Biopharma, Inc.股票,Propanc Biopharma, Inc.股票老虎,Propanc Biopharma, Inc.股票老虎国际,Propanc Biopharma, Inc.行情,Propanc Biopharma, Inc.股票行情,Propanc Biopharma, Inc.股价,Propanc Biopharma, Inc.股市,Propanc Biopharma, Inc.股票价格,Propanc Biopharma, Inc.股票交易,Propanc Biopharma, Inc.股票购买,Propanc Biopharma, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Propanc Biopharma, Inc.(PPCB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Propanc Biopharma, Inc.(PPCB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}